Postgrad LIVE! Study Fairs

Birmingham | Edinburgh | Liverpool | Sheffield | Southampton | Bristol

CeMM Featured PhD Programmes
Imperial College London Featured PhD Programmes
King’s College London Featured PhD Programmes
University College London Featured PhD Programmes
University College London Featured PhD Programmes
10 miles

University of Liverpool Pharmacology / Toxicology PhD Projects, Programs & Scholarships

We have 12 University of Liverpool Pharmacology / Toxicology PhD Projects, Programs & Scholarships

  • Pharmacology / Toxicology×
  • University of Liverpool×
  • clear all
Order by 
Showing 1 to 10 of 12
  Analysing ECG with deep learning: human supervised analysis versus A.I. (Artificial Intelligence)
  Dr R Barrett-Jolley, Dr C Dart
Applications accepted all year round
This is a unique and exciting opportunity to learn new skills in artificial intelligence and ageing biology. You will combine patch-clamp electrophysiology with cutting edge machine learning to predict and understand how cells in the heart age.
  Developing and applying computational methods to understand the genetics of ageing
  Dr JP de Magalhaes
Applications accepted all year round
Ageing is the chief biomedical challenge of the 21st century, yet it remains a major puzzle of biology. Although it is clear that the process of ageing has a strong genetic component, much work remains to elucidate how the genome regulates ageing.
  Targeting ageing: Genes and compounds with pro-longevity, health-preserving effects
  Dr JP de Magalhaes
Applications accepted all year round
Ageing is arguably the major biomedical challenge of the 21st century. In model organisms, the process of ageing can be manipulated by both genetic manipulations and dietary interventions.
  Translation of Cardiovascular Control Models: Are ‘resistant hypertension’ patients truly drug resistant and does neuronal dysregulation contribute?
  Dr R Barrett-Jolley, Prof GYH Lip, Dr A Shantsila
Applications accepted all year round
Hypertension is major health problem across the world affecting 30-40% of adults, and its prevalence continues to grow, especially in developing countries.
  Exploring Stem Cell Regulation by Heparan Sulphates using Chemical Biology and Glycomics Strategies
  Prof J E Turnbull
Applications accepted all year round
Heparan sulphates (HS) are complex sulphated polysaccharides expressed at the cell surface. They are essential co-receptors for many proteins, most notably many signalling growth factors, and they act as dynamic regulators of protein function.
  Defining the importance of mitochondrial genotype in determining individual variation in hepatic fatty acid oxidation and dysregulation
  Dr A Chadwick, Dr A Alfirevic
Application Deadline: 25 January 2019
Applications are invited for a PhD studentship at The MRC Centre of Drug Safety Science, Institute of Translational Medicine, University of Liverpool UK.
  MRC DiMeN Doctoral Training Partnership: Detection of ultra-low frequency heart rate variability markers of disease using AI beat detection and HRV modelling
  Dr R Barrett-Jolley, Dr J Bacardit, Dr I Welters
Application Deadline: 21 January 2019
Background information. If someone says, "my heart beats steady as a rock", they probably need to be warned that this could be a warning of the increased likelihood of an impending heart attack.
  MRC DiMeN Doctoral Training Partnership: Genetic epilepsy: identifying mechanisms and potential drug treatments, from nematodes to humans
  Prof A Morgan, Prof A Trevelyan, Dr A Ilie
Application Deadline: 21 January 2019
Epilepsy is a common neurological disorder that has a major impact on patient mortality, morbidity and quality of life. Clinical management remains extremely problematic, held back both by diagnostic and treatment limitations.
  MRC DiMeN Doctoral Training Partnership: The direct effect of statins on cardiovascular function
  Dr M Cross, Prof J Schneider, Prof H Poptani, Dr B Wilm
Application Deadline: 21 January 2019
Cardiovascular disease (CVD) is the leading cause of death in the western world. The incidence and prevalence of CVD is highest among the elderly due to the deleterious effects of advancing age on the heart and blood vessels1.
  MRC DiMeN Doctoral Training Partnership: Antiretroviral-induced metabolic toxicity: Role of adipose- miRNAs as mechanistic regulators and toxicity biomarkers
  Dr S Pushpakom
Application Deadline: 21 January 2019
Supervisors. Dr S Pushpakom. Prof M Bushell. Prof Sir M Pirmohamed. Background. Diabetes, obesity and cardiovascular disease (collectively called cardiometabolic disease) remain a major public health problem worldwide.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2018
All rights reserved.